Total Funding
47
8
Total FundingGrant raised
Growth Score
-7 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
102261
Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments.
- Martin Childers: Co-founder and Chief Executive OfficerPast Role: Asklepios BioPharmaceutical, CMO
About the Company
Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments for neuromuscular illnesses.
